These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11068780)

  • 1. Enhanced wound healing using topical recombinant human platelet-derived growth factor.
    Seaman S
    Nurse Pract; 2000 Oct; 25(10):85-9. PubMed ID: 11068780
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical PDGF-BB results in limited healing in a patient with Werner's syndrome and chronic leg ulcers.
    Wollina U; Gruner M; Koch A; Köstler E; Hubl W; Hanson NB; Oshima J
    J Wound Care; 2004 Nov; 13(10):415-6. PubMed ID: 15575568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of chronic wound in Klippel-Trenaunay syndrome with recombinant human platelet-derived growth factor-BB.
    Danikas D; Theodorou SJ; Wurmser E
    Plast Reconstr Surg; 2002 Jun; 109(7):2608-9. PubMed ID: 12045617
    [No Abstract]   [Full Text] [Related]  

  • 4. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent.
    Agren MS; Steenfos HH; Dabelsteen S; Hansen JB; Dabelsteen E
    J Invest Dermatol; 1999 Apr; 112(4):463-9. PubMed ID: 10201530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Original articles: ease of wound closure as an endpoint of treatment efficacy.
    Robson MC; Maggi SP; Smith PD; Wassermann RJ; Mosiello GC; Hill DP; Cooper DM
    Wound Repair Regen; 1999; 7(2):90-6. PubMed ID: 10231510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial.
    Senet P; Vicaut E; Beneton N; Debure C; Lok C; Chosidow O
    Arch Dermatol; 2011 Aug; 147(8):926-30. PubMed ID: 21482863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
    Wu L; Brucker M; Gruskin E; Roth SI; Mustoe TA
    Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nitric oxide connection: hyperbaric oxygen therapy, becaplermin, and diabetic ulcer management.
    Boykin JV
    Adv Skin Wound Care; 2000; 13(4 Pt 1):169-74. PubMed ID: 11075012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Becaplermin for wound healing.
    Tecnologica MAP Suppl; 1999 Apr; ():8-12. PubMed ID: 10848163
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.
    Mandracchia VJ; Sanders SM; Frerichs JA
    Clin Podiatr Med Surg; 2001 Jan; 18(1):189-209, viii. PubMed ID: 11344978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy with growth factors.
    Limat A; French LE
    Curr Probl Dermatol; 1999; 27():49-56. PubMed ID: 10547726
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
    LeGrand EK
    Am J Surg; 1998 Aug; 176(2A Suppl):48S-54S. PubMed ID: 9777972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers.
    Miller MS
    J Foot Ankle Surg; 1999; 38(3):227-31. PubMed ID: 10384364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of becaplermin in the closure of pharyngocutaneous fistulas.
    Jakubowicz DM; Smith RV
    Head Neck; 2005 May; 27(5):433-8. PubMed ID: 15776464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of becaplermin gel and Kollagen Medifil particles.
    Tomaselli NL
    J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):319-20. PubMed ID: 11096412
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of recombinant growth factors in wound healing.
    Robson MC; Mustoe TA; Hunt TK
    Am J Surg; 1998 Aug; 176(2A Suppl):80S-82S. PubMed ID: 9777977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology].
    Fruhstorfer B
    Internist (Berl); 2000 Jan; 41(1):A38. PubMed ID: 10712088
    [No Abstract]   [Full Text] [Related]  

  • 18. 3 cases of aberrant wound healing in acute myelogenous leukemia.
    Smith L; Gallison B; Siegler EL
    Adv Skin Wound Care; 2005; 18(9):473-6. PubMed ID: 16365543
    [No Abstract]   [Full Text] [Related]  

  • 19. How growth factors help chronic wounds heal.
    Barry M
    Nursing; 2000 May; 30(5):52-3. PubMed ID: 10855193
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet-derived growth factor for diabetic ulcers.
    Med Lett Drugs Ther; 1998 Jul; 40(1031):73-4. PubMed ID: 9698702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.